Ticker League

AbbVie (ABBV) Free Cash Flow Bridge

Pinpoint what moved AbbVie's free cash flow from TTM through Q1 2025 to TTM through Q1 2026 — operating cash flow shifts and capex changes, each driver sized in dollars.

FCF YoY

+35.62%

OCF YoY

+29.41%

Capex YoY

-64.67%

FCF Conversion Δ

+4.5 pp

Free cash flow bridge for AbbVie (ABBV) — TTM through Q1 2026 vs TTM through Q1 2025

Δ Free cash flow: $5.48B

FCF bridge breakdown for AbbVie (ABBV) — TTM through Q1 2026 vs TTM through Q1 2025

  • Prior Free Cash Flow$15.38B
  • Operating Cash Flow$4.82B
  • Capital Expenditure$657.00M
  • Free Cash Flow$20.86B
Identity check: drivers reconcile to ΔNI within $0.00
Want to see how cash flow is built up?Cash Flow Waterfall

Frequently asked questions

Data & methodology